The Patent Finder

Sutro Biopharma, Inc.

Also on record
Records under this name other than the patents Sutro Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 45 patents it holds.

Back to Sutro Biopharma, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,827,684HUMAN INTERLEUKIN-2 CONJUGATES BIASED FOR THE INTERLEUKIN-2 RECEPTOR BETA GAMMAc DIMER AND CONJUGATED TO A NONPEPTIDIC, WATER-SOLUBLE POLYMER
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,988,619Non-natural amino acid tRNA synthetases for pyridyl tetrazine
Lapsed on the fee record
Ended Jun 5, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 5, 2026USPTO record
US 9,896,685Use of LAMBDA-GAM protein in ribosomal display technology
Lapsed on the fee record
Ended Feb 20, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 20, 2026USPTO record
US 9,840,493Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
Lapsed on the fee record
Ended Dec 12, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 12, 2025USPTO record
US 11,098,131Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies
Lapsed on the fee record
Ended Aug 24, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 24, 2025USPTO record
US 11,014,983Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies
Lapsed on the fee record
Ended May 25, 2025 · USPTO record
Lapsed on the fee recordEnded May 25, 2025USPTO record
US 10,975,150Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodies
Lapsed on the fee record
Ended Apr 13, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 13, 2025USPTO record
US 10,822,414Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodies
Lapsed on the fee record
Ended Nov 3, 2024 · USPTO record
Lapsed on the fee recordEnded Nov 3, 2024USPTO record
US 10,731,148Use of lambda-gam protein in ribosomal display technology
Lapsed on the fee record
Ended Aug 4, 2024 · USPTO record
Lapsed on the fee recordEnded Aug 4, 2024USPTO record
US 10,442,789Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
Lapsed on the fee record
Ended Oct 15, 2023 · USPTO record
Lapsed on the fee recordEnded Oct 15, 2023USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited